Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barré syndrome

Journal of Inflammation

Volumn 7, Issue , 2010, Pages

  Mossberg, Natalia ^a   Andersen, Oluf ^a   Nordin, Magnus ^a   Nilsson, Staffan ^b   Svedhem, Åke ^a   Bergström, Tomas ^a   Hellstrand, Kristoffer ^a   Movitz, Charlotta ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; MYELOPEROXIDASE; OXYGEN RADICAL; PEPTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TRYPTOPHANYLLYSYLTYROSYLMETHIONYLVALYLMETHIONINAMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CAMPYLOBACTER ENTERITIS; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HERPES ZOSTER; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS A; LEUKOCYTE FUNCTION; MALE; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; RESPIRATORY BURST; RESPIRATORY SYNCYTIAL VIRUS INFECTION; UPPER RESPIRATORY TRACT INFECTION;

EID: 77955203550     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-7-40     Document Type: Article

References (35)

1. Recurrent Guillain-Barre syndrome. Clinical and laboratory features. F Grand'Maison TE Feasby AF Hahn WJ Koopman, Brain 1992 115 Pt 4 1093 1106 10.1093/brain/115.4.1093 1393505
2. Recurrent Guillain-Barre syndrome: lightning does strike twice. TA Roper SM Alani, Br J Hosp Med 1995 53 403 407 7599902
3. Recurrent Guillain Barre' syndrome. A Das J Kalita UK Misra, Electromyogr Clin Neurophysiol 2004 44 95 102 15061403
4. Assessment of current diagnostic criteria for Guillain-Barre syndrome. AK Asbury DR Cornblath, Ann Neurol 1990 27 Suppl 21 24 10.1002/ana.410270707 2194422
5. Diagnostic and classification criteria for the Guillain-Barre syndrome. FG Van der Meche PA Van Doorn J Meulstee FG Jennekens, Eur Neurol 2001 45 133 139 10.1159/000052111 11306855
6. Phagocytes and oxidative stress. BM Babior, Am J Med 2000 109 33 44 10.1016/S0002-9343(00)00481-2 10936476
7. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. P Olofsson J Holmberg J Tordsson S Lu B Akerstrom R Holmdahl, Nat Genet 2003 33 25 32 10.1038/ng1058 12461526
8. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. M Hultqvist P Olofsson J Holmberg BT Backstrom J Tordsson R Holmdahl, Proc Natl Acad Sci USA 2004 101 12646 12651 10.1073/pnas.0403831101 15310853
9. Advanced intercross line mapping suggests that ncf1 (ean6) regulates severity in an animal model of guillain-barre syndrome. A Huberle AD Beyeen J Ockinger M Ayturan M Jagodic KL de Graaf N Fissolo M Marta P Olofsson M Hultqvist, et al. J Immunol 2009 182 4432 4438 10.4049/jimmunol.0803847 19299744
10. Oxygen radical production and severity of the Guillain - Barre syndrome. N Mossberg O Andersen S Nilsson C Dahlgren K Hellstrand M Lindh A Svedhem T Bergstrom C Movitz, J Neuroimmunol 2007 192 186 191 10.1016/j.jneuroim.2007.09. 020 17945354
11. Oxygen radical production in leukocytes and disease severity in multiple sclerosis. N Mossberg C Movitz K Hellstrand T Bergstrom S Nilsson O Andersen, J Neuroimmunol 2009 213 131 134 10.1016/j.jneuroim.2009.05.013 19589606
12. Recurrent Guillain-Barre syndrome. K Kuitwaard R van Koningsveld L Ruts BC Jacobs PA van Doorn, J Neurol Neurosurg Psychiatry 2009 80 56 59 10.1136/jnnp.2008.156463 18931012
13. Distinguishing acute-onset CIDP from Guillain-Barre syndrome with treatment related fluctuations. L Ruts R van Koningsveld PA van Doorn, Neurology 2005 65 138 140 10.1212/01.wnl.0000167549.09664.b8 16009902
14. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. RA Hughes P Bouche DR Cornblath E Evers RD Hadden A Hahn I Illa CL Koski JM Leger E Nobile-Orazio, et al. Eur J Neurol 2006 13 326 332 10.1111/j.1468-1331.2006.01278.x 16643309
15. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. RP Kleyweg FG van der Meche PI Schmitz, Muscle Nerve 1991 14 1103 1109 10.1002/mus.880141111 1745285
16. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. A Boyum, Scand J Clin Lab Invest Suppl 1968 97 77 89 4179068
17. JA Metcalf JI Gallin WM Nauseef R K Root, Laboratory Manual of Neutrophil Function 1986
18. Respiratory burst in human neutrophils. C Dahlgren A Karlsson, J Immunol Methods 1999 232 3 14 10.1016/S0022-1759(99)00146-5 10618505
19. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. H Lundqvist C Dahlgren, Free Radic Biol Med 1996 20 785 792 10.1016/0891-5849(95)02189-2 8728025
20. Myeloperoxidase: friend and foe. SJ Klebanoff, J Leukoc Biol 2005 77 598 625 10.1189/jlb.1204697 15689384
21. Diffusion-in-gel enzyme-linked immunosorbent assay for routine detection of IgG and IgM antibodies to Campylobacter jejuni. A Svedhem H Gunnarsson B Kaijser, J Infect Dis 1983 148 82 92 6411829
22. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. RD Ye F Boulay JM Wang C Dahlgren C Gerard M Parmentier CN Serhan PM Murphy, Pharmacol Rev 2009 61 119 161 10.1124/pr.109.001578 19498085
23. Phorbol myristate acetate mediates redistribution of protein kinase C in human neutrophils: potential role in the activation of the respiratory burst enzyme. M Wolfson LC McPhail VN Nasrallah R Snyderman, J Immunol 1985 135 2057 2062 3160785
24. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. SH Jackson S Devadas J Kwon LA Pinto MS Williams, Nat Immunol 2004 5 818 827 10.1038/ni1096 15258578
25. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. M Hansson A Asea U Ersson S Hermodsson K Hellstrand, J Immunol 1996 156 42 47 8598491
26. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice. M Hultqvist J Backlund K Bauer KA Gelderman R Holmdahl, J Immunol 2007 179 1431 1437 17641008
27. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. Y Gilgun-Sherki E Melamed D Offen, J Neurol 2004 251 261 268 10.1007/s00415-004-0348-9 15015004
28. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. M Minohara T Matsuoka W Li M Osoegawa T Ishizu Y Ohyagi J Kira, J Neuroimmunol 2006 178 156 160 10.1016/j.jneuroim.2006.05.026 16839613
29. Immune deficiency and autoimmunity. A Etzioni, Autoimmun Rev 2003 2 364 369 10.1016/S1568-9972(03)00052-1 14550878
30. The protective role of ROS in autoimmune disease. M Hultqvist LM Olsson KA Gelderman R Holmdahl, Trends Immunol 2009 30 201 208 10.1016/j.it.2009.03.004 19356981
31. Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. JR Korzenik BK Dieckgraefe, Dig Dis Sci 2000 45 1121 1129 10.1023/A:1005541700805 10877227
32. Genetic, biochemical, and clinical features of chronic granulomatous disease. BH Segal TL Leto JI Gallin HL Malech SM Holland, Medicine (Baltimore) 2000 79 170 200 10.1097/00005792-200005000-00004 10844936
33. Chronic granulomatous disease as a risk factor for autoimmune disease. SS De Ravin N Naumann EW Cowen J Friend D Hilligoss M Marquesen JE Balow KS Barron ML Turner JI Gallin HL Malech, J Allergy Clin Immunol 2008 122 1097 1103 10.1016/j.jaci.2008.07.050 18823651
34. ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. KL Brown J Bylund KL MacDonald GX Song-Zhao MR Elliott R Falsafi RE Hancock DP Speert, Clin Immunol 2008 129 90 102 10.1016/j.clim.2008.06.005 18676204
35. Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies. KA Gelderman M Hultqvist LM Olsson K Bauer A Pizzolla P Olofsson R Holmdahl, Antioxid Redox Signal 2007 9 1541 1567 10.1089/ars.2007.1569 17678439